Our people

How curious minds saved a medicine from being left in the lab

Patients & consumers

Soccer Star Shannon Boxx Takes Her Shot at Lupus Advocacy

While Shannon was winning some pretty tough battles on the field, she was privately facing her toughest battle off the field: lupus.

Access to healthcare

Pricing our medicines to help ensure patient access

We know there is significant frustration in the US regarding the cost of healthcare – including prescription medicines. We take this very seriously, as evidenced by our pricing track record.

Access to healthcare

Helping patients in need

Insurance coverage can be challenging, financial circumstances can change quickly, and sometimes patients need assistance paying for their prescription medications or vaccines.

How we do business

Changing the way we do business

When was the last time you upended your life – reevaluated the way you work, radically shifted how you measure success – and convinced 100,000 people to do it with you?

How we do business

Fast-tracking our response to pandemics

How we do business

Putting it plainly

How we do business

Hunting for energy savings

You never know what you might find when you hunt for waste.

How we do business

Creating bricks and benches out of medical waste

Instead of being incinerated, medical lab waste at our Upper Providence site is being upcycled into bricks and benches.

How we do business

Evolving our graduated approach to intellectual property

In developing countries, millions of people have no access to even the most basic healthcare services, including safe and effective medicines.

Our people

Building future leaders

Everyone talks about “leadership.” Business schools teach courses on it and war metaphors abound. Great leaders are often described as near-mythical creatures - like unicorns.

Our people

Designing inspiring and healthy workplaces

Innovation

On target for a new era of drug discovery?

Patients & consumers

GSK IMPACT Awards: 20 years of healthy communities

The GSK IMPACT Awards recognize local nonprofit organizations in our hometowns of Greater Philadelphia, PA and the Triangle Region, NC that are working to improve health hand-in-hand with the community.

How we do business

Buyer beware: importing drugs comes with big risks

At first blush, importing medicines sounds great – a patient without insurance or facing a high deductible or co-pay may find the prices quite attractive. But importation carries major risks.

How we do business

How doctors and insurers get information about medicines for patients

How do doctors and insurers in the US get the info they need to make decisions about medicines for patients?

Our people

The gift of time: increased parental leave

We all want the time and energy to invest in the things that matter most. That is why GSK is expanding our paid parental leave benefit in 2017.

Our people

Work Together, Give Together

Our people

Engineers as leaders: The art of the possible over the probable

Patients & consumers

Living with COPD Every Day: Sean’s Story

Pinch your nose and try breathing through a straw? Not so easy, right?

Our people

Making healthy cool in school through Get HYPE Philly!

Priscilla is quick to tell you she’s not looking forward to this school year; how her sister drives her nuts; and how doubling up on algebra and geometry is going to make this year tougher than any before.

Patients & consumers

Whooping cough: confronting the hidden risk to infants

Whooping cough can be especially serious for infants—sometimes even fatal.

Our people

From the GSK archives: William Allen, scientist, businessman, abolitionist

When a company is as old as GSK (300 years this year!), the archives swell with items and documents related to our corporate heritage.

Patients & consumers

Inspiring Students through STEM Education Programs

Innovation

Scientists or detectives? Seeking new clues in COPD

How we do business

Helping to Change the World

FORTUNE Magazine published its 2016 list of companies that are changing the world, and we are honored to be ranked #1.

Our people

The global as personal: GSK and The National Museum of African American History and Culture

We are incredibly proud to be a Founding Donor of The National Museum of African American History and Culture in the Smithsonian Institution.

Innovation

Can an iPhone transform the way we monitor and improve patient health?

Since 2014, we’ve been transforming the way we do research using digital technologies and channels to improve the efficiency of our research, and to improve patient care.

Patients & consumers

Take a Breather: 8 Fast Facts on Severe Asthma

You may know about asthma, and that 26 million people in the US have it. But, how much do you know about severe asthma?

Our people

Changing gears in a scientific career

Our people

Persevering to accelerate your career success: lessons from an engineer

How we do business

Letting the sunshine in – transparency that’ll grow trust

Transparency for the sake of transparency seems a fruitless endeavor. Done right, however, it can be very powerful in strengthening relationships and forging new partnerships.

Patients & consumers

The power of advocacy: coming together for the patient

When it comes to patient care, information sharing is vital – between the patient and doctor, and among multiple members of the care team. But did you ever think that information sharing is equally important during the research process, long before a new medical therapy reaches patients?

Access to healthcare

Global mission, local impact

We often hear of humanitarian work in other parts of the world, but here in the United States there is real need as well. Around 47 million in the US live in poverty.

Our people

From academia to industry: a new challenge

Professor Christopher Cooper joined GSK as a Global Medical Expert, Scientific Faculty, GSK Global Respiratory Franchise. Here he explains why he chose to move from academia to industry.

Our people

Andy Dundon: the design behind the device

Innovation

Turning the tide on antibiotic resistance

Our people

Clinical Trials: Q&A with Murray Stewart

Dr. Murray Stewart is our Chief Medical Officer. In this role, he is the most senior physician at GSK, and has overall responsibility for patient well-being across vaccines, pharmaceutical and consumer medicines. He also oversees medical ethics and integrity.

Patients & consumers

Beyond Breathing: When Is Asthma Really Under Control?

Often, despite trying many different asthma management techniques – from medication to avoiding triggers – patients have told me they were still experiencing asthma symptoms on a regular basis.

Patients & consumers

GSK Uncovers The State of Uncontrolled Asthma in America

Survey findings show more than two-thirds (67%) of adults with uncontrolled asthma in the US are living with the misperception that their condition is under control.

Our people

Respiratory disease: why we want to make a difference

Today too many people suffer unnecessarily because of the poor management of their asthma and COPD.

Access to healthcare

In Africa, markets matter for a healthy society

Our people

Safety first: Employee wellbeing rides on it

Our people

Beyond manufacturing in Chile and Madagascar

In 2015, GSK Vaccines sent two vaccine manufacturing teams to South America and Africa to better understand the impact of their daily work.

Our people

Why I fight malaria: Laura's story

Laura is a scientist and a mom. Here she describes what motivates her to fight against malaria.

Our people

Making the global goals our business

Not everyone gets to live their dream job, but I feel extremely lucky and grateful that I do. I lead GSK’s global employee volunteering efforts, including PULSE, our flagship program.

Patients & consumers

8 simple activities that may not be so simple when you have severe asthma

Saying “I have asthma” may not be as simple as you think. There are different types of asthma, including mild, moderate or severe asthma and each can make every day activities difficult in their own way.

Innovation

Take a deep breath - your lung microbiome will appreciate it

Our people

Gary the "Resourceful Recycler”

Our people

Tracy the "Courageous Problem-Solver”

Tracy has been a driving force behind GSK’s progress in the US and around the world. She also plays an important role in a number of diversity organizations.

Our people

George the "Science Liaison Leader”

George, GSK Medical Science Liaison Director, has his Pharm.D., is based in Dallas, TX, has worked for GSK for fourteen years, and manages of a team of eight other Medical Science Liasons.

Our people

Linda the "Neighborhood Health Advocate”

Linda, GSK Community Partnership Representative, 26-year employee of GSK, the second in a three-generation family of GSK’ers, and a Philadelphia native.

Our people

Putting responsible business principles into practice

Our responsible business reforms are taking hold here in the US market and with our US employees.

Innovation

GSK’s Chief Immunology Officer discusses unlocking the secrets of the immune system to tackle disease

Patients & consumers

Launching the Fostering Wellness initiative – young people, lead the way!

Our people

Charting a path to success: my International Women's Day advice is for everyone

As a physician, a senior executive, a researcher and a parent, I play many roles – but I don’t often stop to think about my gender.

Innovation

Harnessing the electrical language of the body to treat disease

Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.

Our people

Rare Disease Day 2016: What it means to us

Rare Disease Day on 29th February holds personal significance for two colleagues working in our Rare Disease Unit; Jessica Imrie and Julie Venners Christensen both have children with rare disorders.

Our people

On the job with GSK's medical device research team

A mechanical engineering graduate on a GSK Future Leaders Programme is helping to develop user-friendly devices to administer treatments safely.

Our people

Volunteering in Kenya: a once in a lifetime experience

Our people

Treating malaria: Making a change from the inside

Our people

Simon Wright, Head of Child Survival at Save the Children gives a partnership perspective

Simon Wright, Head for Child Survival at Save the Children, talks about how we’re working together to make sure the health needs of the world’s poorest children are at the top of everyone’s agenda.

Patients & consumers

The Power of 24hrs

On November 13, 2008, Jamie Schanbaum, then 20 years old and enjoying the life of a typical college student, was feeling ill. Her symptoms were similar to those of the common flu but within 14 hours she was admitted to a hospital, in Austin, TX.

Access to healthcare

TEDMED 2015: An interview with curator, Christine McNab

How does art tell the story of vaccines in a different way than other communications media?

Access to healthcare

TEDMED 2015: Art, inspired by vaccination

There are surprising similarities between an artist beginning a new work and a researcher on a quest to develop a vaccine.

Access to healthcare

Giving mothers and babies a healthier start

Our people

War and peace: Ivo, Nobel prize winner

Our people

Changing Lives

The PULSE Volunteer program is GSK’s flagship skills-based volunteering initiative. Launched in 2009, PULSE serves as a matchmaker for GSK and the non-profit sector – connecting the skills of our high-performing employees with the pressing needs of our non-profit partners.

Innovation

Rare diseases: Q&A with Martin Andrews

Martin Andrews leads our Rare Diseases Unit to help advance the treatment of patients affected by rare diseases. He was appointed Senior Vice President, GSK Rare Diseases in November 2013.

How we do business

The hope for a cure for HIV/AIDS in our lifetime

In the past three decades, we’ve made advances in treatments for HIV/AIDS but a cure has remained elusive.

Patients & consumers

Every breath you take: Alison’s story

Imagine if every breath you took was a struggle; imagine waking up in the night short of breath and wheezing.

Innovation

Cell and gene therapy: a new era of medicine

Innovation

The race to richer data in clinical trials

How we do business

Switching on to consumer choice: medicines for everyday health

How our consumer strategy is improving quality of life and access to established medicines

Access to healthcare

Our humanitarian response to the Ebola outbreak

GSK's on-going efforts to strengthen healthcare infrastructure in the most affected countries.

Access to healthcare

Malaria: life cycle of a parasite

Find out more about malaria and the life cycle of the parasites that cause it.

How we do business

Changing the way we work with healthcare professionals

Putting patients’ interests at the heart of every decision.

How we do business

Flonase: the journey from prescription to OTC

Access to healthcare

The fight against malaria

Patients & consumers

Clinical trials: a patient's view

In 2009 John Patrick Murphy, a 68 year old trial lawyer from Colorado, took a run-of-the-mill fall, which caused him a great deal of pain in his leg.

Innovation

Epigenetics: turn-ons and turn-offs

In the words of the author and biochemist Isaac Asimov, "The most exciting phrase to hear in science, the one that heralds new discoveries, is not 'Eureka!', but 'That's funny…'"

Patients & consumers

Science of a different stripe

How do the stripes in toothpaste get into the tubes and how is it that they come out of it so uniformly?

Innovation

Neuroscience: on the brain

The number of people living with dementia worldwide is set to treble by 2050 to 135 million, according to the World Health Organization.

Innovation

Can mosquitoes prevent malaria?

Patients & consumers

Eggs in manufacturing

Innovation

Bacteria: friends or foes?

What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?

Innovation

Data transparency

We have a long-standing commitment to data transparency.

Innovation

Inside the open lab

"The biggest surprise for me was the openness,” says Thulasi Warrier. “I thought I would be put in a cubicle and not encouraged to speak.”

How we do business

Green chemistry

Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use.

Access to healthcare

Collaborating to improve patient care

Patients & consumers

Struggling for breath

How we do business

Biosecurity and pandemic preparedness

Our global commitment to helping ensure health for all is built on developing innovative medicines and vaccines and making sure they’re accessible to people around the globe.

Back to top